Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma

por Abdel-Wahab, Reham, Shehata, Samir, Hassan, Manal M., Xiao, Lianchun, Lee, Ju-Seog, Cheung, Sheree, Essa, Hoda H., Hassabo, Hesham M., Shalaby, Ahmed S., Mosad, Eman, Raghav, Kanwal, Rashid, Asif, Wolff, Robert A., Morris, Jeffrey S., Amin, Hesham M., Kaseb, Ahmed O.
Publicado 2015

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

por Kaseb, Ahmed O, Morris, Jeffrey S, Iwasaki, Michiko, Al-Shamsi, Humaid O, Raghav, Kanwal Pratap Singh, Girard, Lauren, Cheung, Sheree, Nguyen, Van, Elsayes, Khaled M, Xiao, Lianchun, Abdel-Wahab, Reham, Shalaby, Ahmed S, Hassan, Manal, Hassabo, Hesham M, Wolff, Robert A, Yao, James C
Publicado 2016

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma

por Kaseb, Ahmed O., Xiao, Lianchun, Hassan, Manal M., Chae, Young Kwang, Lee, Ju-Seog, Vauthey, Jean-Nicolas, Krishnan, Sunil, Cheung, Sheree, Hassabo, Hesham M., Aloia, Thomas, Conrad, Claudius, Curley, Steven A., Vierling, John M., Jalal, Prasun, Raghav, Kanwal, Wallace, Michael, Rashid, Asif, Abbruzzese, James L., Wolff, Robert A., Morris, Jeffrey S.
Publicado 2014